Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

Helicobacter pylori (H. pylori) is a stomach-colonizing bacterium that can cause chronic gastritis, peptic ulcers, gastric adenocarcinoma, and MALT lymphoma. An estimated 30–40% of the US population is infected, with many cases remaining asymptomatic. According to Helicobacter Pylori Infection Epidemiology Forecast by Expert Market Research (EMR), the disease burden is shaped by transmission conditions, socioeconomic circumstances, access to testing, and the effectiveness of eradication treatment.

2025

Base Year

2019-2025

Historical Period

2026-2035

Forecast Period

Helicobacter Pylori Infection – Number of Cases by Year

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Helicobacter Pylori Infection Epidemiology Forecast Report Coverage

Expert Market Research's “Helicobacter Pylori Infection Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of Helicobacter Pylori Infection. It projects the future incidence and prevalence rates of Helicobacter Pylori Infection cases across various populations. The study covers age, gender, and type as major determinants of the Helicobacter Pylori Infection population. The report highlights patterns in the prevalence of Helicobacter Pylori Infection over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of Helicobacter Pylori Infection in the 8 major markets.

Regions Covered

  • United States
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Japan
  • India

Helicobacter Pylori Infection Understanding: Disease Overview

Helicobacter pylori (H. pylori) infection is a highly prevalent bacterial condition affecting over 50% of the global population. This spiral-shaped, Gram-negative bacterium targets the human gastric mucosa, making it the leading cause of peptic ulcer disease and a designated Class 1 carcinogen linked to stomach cancer. While a vast majority of infected individuals remain asymptomatic, chronic colonization inevitably leads to varying degrees of stomach lining inflammation.

Key Report Insights

Parameter

Insight

Largest Patient Pool

India

Fastest Growing Country

United States

High-Risk Population

Higher-risk groups include people living in crowded or inadequately sanitized conditions, individuals from households or communities where infection is common, and people with a family history of gastric cancer or relevant gastric disease.

Key Diagnostic Method

For detecting active infection, the principal non-invasive tests are the urea breath test and stool antigen test. Upper gastrointestinal endoscopy with gastric biopsies may be appropriate when endoscopic assessment is clinically indicated; biopsy-based methods can also identify infection and, in selected settings, support antimicrobial susceptibility testing.

Major Risk Factor

A major epidemiological risk factor is exposure within households or communities where H. pylori transmission is established, with crowding and inadequate sanitation potentially contributing to transmission.

Major gap in the market

A major gap is the lack of comparable, recent population-level prevalence data and routine local antimicrobial susceptibility surveillance across the eight countries. Other gaps include uneven access to non-invasive testing, incomplete confirmation of eradication, and limited use of susceptibility-guided treatment after therapeutic failure.

Helicobacter Pylori Infection Epidemiology Perspective

The Helicobacter Pylori Infection epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for the Helicobacter Pylori Infection epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for Helicobacter Pylori Infection and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

Epidemiology Segment

Key Insights

Diagnosed Prevalent Cases of the Disease

The estimated global prevalence of Helicobacter pylori (H. pylori) infection is approximately 43% to 44% of the worldwide adult population (and roughly 35% among children and adolescents), translating to over 4 billion chronically infected individuals globally.

Gender-Specific Cases of the Disease

Male sex is associated with a slightly higher overall prevalence of Helicobacter pylori infection (summary odds ratio around 1.12 to 1.16), though the distribution changes across specific age groups. Large cross-sectional studies show that older women (aged 60+) experience a higher infection risk and higher 1-year recurrence rates after treatment compared to men in the same older brackets.

Age-Specific Cases of the Disease

Adults who are currently over the age of 50 or 60 lived their early childhoods during mid-to-late 20th-century environments with lower sanitation infrastructure, less public water treatment, and higher household crowding. They acquired the bacteria as children and have carried it lifelong, leading to modern adult prevalence rates reaching 40% to 70%+ depending on the country.

Ethnicity-Wise Cases of the Disease

Black/African American Individuals, prevalence ranges from 40% to 54%, representing a roughly 1.3- to 5.4-fold higher likelihood of infection compared to non-Hispanic Whites. Significant racial and ethnic disparities exist in Helicobacter pylori (H. pylori) infection prevalence, with non-White and immigrant ethnic groups consistently demonstrating substantially higher rates of colonization compared to majority White or native populations in Western countries.

Mortality and Survival Analysis of the Disease

Mortality is principally associated with complications of persistent infection, particularly gastric cancer, rather than with uncomplicated colonization itself. Directly linked to severe complications like peptic ulcers and gastric cancer, Helicobacter pylori infection contributes globally to over 660,000 to 769,000 gastric cancer deaths annually, positioning stomach cancer as one of the leading causes of cancer-related mortality worldwide.

Helicobacter Pylori Infection – Number of Cases by Country

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Country-wise Helicobacter Pylori Infection Epidemiology

The Helicobacter Pylori Infection epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Country

Key Insights

United States

In the United States, the overall prevalence of Helicobacter pylori (H. pylori) infection is estimated to be between 30% and 40% of the general population. While the total number of infections has steadily declined over the past few decades due to advanced sanitation and widespread antibiotic treatments, substantial disparities remain across specific age groups, ethnicities, and geographic regions.

Germany

In Germany, the estimated overall prevalence of Helicobacter pylori infection ranges between 25% and 35% of the general population, showing a significant decline over recent decades. Older nationwide health surveys from the late 1990s and 2000s recorded an overall seroprevalence of roughly 40%, but more contemporary clinical and regional studies show lower rates averaging about 25% to 30%.

France

In France, the estimated prevalence of Helicobacter pylori infection in the general adult population ranges between 15% and 30%. Similar to other highly industrialized Western European nations, the overall frequency of the infection has experienced a steady downward trend over recent decades due to heightened hygiene standards and active clinical eradication.

Italy

In Italy, the estimated overall prevalence of Helicobacter pylori infection affects more than one-third of adults (approximately 35% to 40% of the general population), with recent multicenter endoscopic and clinical data reporting active infection rates around 22% to 30% depending on the cohort and age distribution.

Spain

In Spain, the estimated prevalence of Helicobacter pylori infection in the general population hovers around 50% to 55%. Compared to other major Western European nations like France and Germany, Spain features a noticeably higher burden of the infection, displaying epidemiological patterns intermediate between highly industrialized and developing regions

United Kingdom

In the United Kingdom, the overall prevalence of Helicobacter pylori infection is estimated to affect up to 35% to 40% of the population (or roughly up to 2 in 5 people), though contemporary clinical data indicates that in many areas the baseline rate has dropped below 15% and continues to fall.

Japan

In Japan, the estimated overall prevalence of Helicobacter pylori infection is approximately 35% to 42% of the general adult population, showing a steep and continuous generational decline.

India

In India, the overall prevalence of Helicobacter pylori (H. pylori) infection is remarkably high, estimated to affect 60% to 70% of the general population, translating to potentially over 800 million to 900 million people carrying the bacterium.

Key Market Gaps, Untapped Opportunities, and Emerging Growth Areas in the Regional Disease Epidemiology Landscape

Across the eight countries, the clearest opportunities are expanded access to reliable active-infection testing, routine confirmation of eradication, and better local surveillance of antimicrobial resistance. Susceptibility-guided treatment can help avoid ineffective antibiotic combinations, especially after previous treatment failure. Additional epidemiological priorities include representative prevalence surveys, standardized reporting of diagnosed infection, and clearer linkage between infection, gastric premalignant disease and cancer outcomes. These are evidence and service-delivery opportunities; current data do not support a reliable ranking of the eight countries by prevalence growth.

Helicobacter Pylori Infection: Treatment Overview

Treatment aims to eradicate the bacterium and confirm successful clearance. The 2024 American College of Gastroenterology guideline recommends 14-day bismuth quadruple therapy as the preferred empirical regimen for treatment-naïve patients when antibiotic susceptibility is unknown; selected alternatives include rifabutin-based triple therapy or potassium-competitive acid blocker-amoxicillin dual therapy. Clarithromycin- or levofloxacin-containing regimens should be used only when susceptibility is confirmed. Regimen selection must follow applicable national guidance, allergy history and prior antibiotic exposure. Eradication should be confirmed with a urea breath test, stool antigen test or appropriate biopsy-based test after treatment.

Key Questions Answered

  • What is the current and projected burden of Helicobacter Pylori Infection across the 8 major markets?
  • Which countries across the 8 major markets account for the highest Helicobacter Pylori Infection patient populations and fastest growth rates?
  • What is the diagnosed versus undiagnosed patient population of Helicobacter Pylori Infection across key countries in the 8 major markets?
  • Which countries demonstrate the largest gaps in screening, early diagnosis, and disease awareness of Helicobacter Pylori Infection across the 8 major markets?
  • What are the major drivers contributing to the increasing burden of Helicobacter Pylori Infection across the 8 major markets?
  • How do major comorbidities and risk factors influence Helicobacter Pylori Infection epidemiology trends across the 8 major markets?
  • What are the regional trends in advanced disease progression, treatment uptake, and patient management of Helicobacter Pylori Infection across the 8 major markets?
  • Which patient segments represent the highest unmet clinical need in the Helicobacter Pylori Infection landscape across the 8 major markets?
  • Which therapeutic areas linked to Helicobacter Pylori Infection are expected to witness the strongest growth opportunities across the 8 major markets?
  • How is the Helicobacter Pylori Infection epidemiology landscape expected to evolve over the next 5 to 10 years across the 8 major markets?
  • Which countries across the 8 major markets offer the most attractive market opportunities based on Helicobacter Pylori Infection epidemiology and healthcare infrastructure?
  • Which epidemiological trends are expected to influence future drug development and market access strategies for Helicobacter Pylori Infection across the 8 major markets?

Scope of the Helicobacter Pylori Infection Epidemiology Report

  • The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of Helicobacter Pylori Infection based on several factors.
  • Helicobacter Pylori Infection Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
  • The Helicobacter Pylori Infection report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Bacterial Disease Diagnostics Market

Gastric Ulcer Treatment Market

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

Report Features

Details

Base Year

2025

Historical Period

2019-2025

Forecast Period

2026-2035

Epidemiology Statistics Provided

  • Diagnosed Prevalent Cases
  • Type-Specific Cases
  • Gender-Specific Cases
  • Age-Specific Cases

Segmentation Provided

  • Epidemiology by Age Group
  • Epidemiology by Gender
  • Epidemiology by Type of Disease
  • Epidemiology by Region

Geographies Covered

  • United States
  • Germany
  • Italy
  • France
  • Spain
  • United Kingdom
  • Japan
  • India

Datasheet

10 % Off

USD

2,699

2,429

Single User License

10 % Off

USD

4,299

3,869

Five User License

15 % Off

USD

5,799

4,949

Corporate License

15 % Off

USD

6,999

5,949

Datasheet

One User

USD 2,699

USD 2,429

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 4,299

USD 3,869

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 5,799

USD 4,949

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 6,999

USD 5,949

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

This is a collaborative report by Vishakha Agrawal reflecting perspectives and research-driven insights from Expert Market Research.

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

License Type

Select License Type

Choose the right license for your needs and access rights.

shopping cart

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Bookmark Icon

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us